Early Detection Research Network

Clinical implementation of soluble EGFR (sEGFR) as a theragnostic serum biomarker of breast, lung and ovarian cancer.

No abstract available.

Baron AT, Goodrich ST, Haggstrom DE, Maihle NJ, Wilken JA

19431095

IDrugs, 2009, 12 (5)